Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years

Scope of the guidance

This item provides guidance on best practice in:

  • diagnosis and assessment of the impact of atopic eczema in children
  • management during and between flare-ups of atopic eczema
  • information and education for children and their families about atopic eczema

Atopic eczema is a chronic, relapsing, and itchy inflammatory skin condition. In the acute stage, eczematous lesions are characterised by poorly defined erythema with surface change (oedema, vesicles and weeping). In the chronic stage, lesions are marked by skin thickening (lichenification). Atopic eczema affects about 15-20% of school age children at sometime. (See Clinical Evidence Handbook in Further Reading).

 

Source

National Institute for Clinical Excellence. Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years. NICE Clinical Guidelines 57.  London: NICE, 2007.

www.nice.org.uk/nicemedia/pdf/CG057NICEguideline.pdf 

 

Key points

1. Diagnosis

  • A diagnosis of atopic eczema in a child is made if there is an itchy skin rash plus three or more of:

             o      visible dermatitis in skin creases

             o      history of flexural dermatitis

             o      history of dry skin

             o      history of asthma or allergic rhinitis

             o      onset of the rash below the age of two years

  • In Asian, black Caribbean and black African children atopic eczema often affects the extensor surfaces; discoid or follicular patterns may be more common.

2. Assessment

  • Take into account:

             o      pattern and severity

             o      previous treatments and response to those treatments

             o      possible trigger factors

             o      impact of the disease on the child / family e.g. on everyday activities or sleep.  There is not always a direct relationship between severity of eczema and its impact on a child’s quality of life.

 

3. Trigger Factors

  • Common trigger factors include:

             o      irritants e.g. soaps and detergents

             o      skin infections

             o      contact allergens, especially if the eczema responds to topical treatment

             o      inhaled allergens, especially if the eczema is seasonal or is associated with asthma or allergic rhinitis

  • Advise parents that most children with eczema do not need allergy testing.

4. Treatments

  • Treatment of atopic eczema should be based on a ‘stepped-care plan’ where treatments are stepped up or down depending on your assessment of the state of the child’s skin.

             o      Step 1: clear skin. Use emollients only.

             o      Step 2: mild – areas of dry skin, and infrequent itching.  Use emollients alone or combined with a topical steroid of mild potency.

             o      Step 3: moderate – areas of dry skin, frequent itching and redness.  Use emollients with a topical steroid of moderate potency (body: 7-14 days, face 3-5 days use), bandages, (then a topical calcineurin inhibitor such as tacrolimus - but only initiated under specialist dermatological supervision).

             o      Step 4: severe – widespread areas of dry skin, incessant itching, redness.  Use emollients, potent topical steroids (moderate potency on the face or neck), bandages, (then tacrolimus, phototherapy or systemic treatment – but only initiated under specialist dermatological supervision).

  • Emollients:

             o      are the best treatment when the diagnosis of atopic eczema is clear

             o      should be prescribed in large quantities. 

             o      can be used instead of soap, and instead of shampoo for infants.

  • Topical steroids: potency should be tailored to the severity of the child’s atopic eczema across their body:

             o      use mild potency for mild atopic eczema

             o      use moderate potency for moderate atopic eczema

             o      use potent topical corticosteroids for severe atopic eczema

             o      use mild potency for the face and neck except short term (3-5 days) use of moderate potency for severe flares

             o      use moderate or potent corticosteroids for short periods only (7-14 days) for flares in vulnerable sites such as axillae and groin

             o      do not use very potent corticosteroids in children without specialist dermatological advice

             o      if a mild or moderate topical steroid has not controlled the eczema within 7-14 days, consider whether a secondary bacterial or viral infection might be present.  If a potent steroid fails to work over a short time, refer the child to a dermatologist.

  •  Tacrolimus:

             o      is a second-line treatment and should only be started by doctors with a special interest in dermatology.

             o      should not be used under bandages or dressings, without dermatological advice.

             o      An association has been suggested between tacrolimus and skin cancer (see Clinical Evidence Handbook in Further Reading)

  • Bandages and dressings:

             o      use on top of emollients, or on top of emollients plus topical steroid.

  • Phototherapy:

             o      use when other treatments for eczema have failed.

             o      should be initiated and organised by a specialist dermatologist.

  • Antihistamines:

             o      a one month trial of a non-sedating antihistamine can be used for children with severe atopic eczema, or children with mild / moderate eczema with severe itching or urticaria.  Continue if the trial is successful.

             o      a 1-2 week course of a sedating antihistamine can be used for an acute flare of dermatitis, where the child’s sleep is being affected.

  • Flare-ups:

             o      give parents information about how to recognise flares.

start treatment for flare-ups as soon as there are symptoms or signs

 

5. Infections

  • Remind parents to beware that containers of topical treatment can become contaminated which could lead to re-infection. For this reason, such containers should be replaced once a skin infection has been treated.
  • Bacterial infection:

             o      tell parents of the signs and symptoms to watch out for: weeping, pustules, crusting and sudden worsening of the rash.

             o      swab if you suspect a bacteria other than Staph. aureus or if you think there might be antibiotic resistance.

             o      treat with topical antibiotics (can be combined with topical steroids) for localised infection, or systemic antibiotics for widespread infection.

  • Herpes infection:

             o      in all children with eczema with a severe flare consider if the skin is infected with herpes simplex – that is, eczema herpeticum. If so, treat as an emergency and consider prescribing systemic aciclovir immediately and refer for an emergency dermatological opinion.

             o      if the rash involves the skin around the eyes, you may need you may need to prescribe prophylactic ocular acyclovir and consider referral for an emergency opthalmological opinion too.

             o      if you think that there might be secondary bacterial infection as well, then start systemic antibiotics.

 

6. Referral to dermatological specialist

  • Emergency referral if you suspect eczema herpeticum
  • Urgent (within two weeks) if the eczema is severe and has failed to respond to topical therapy or treatment of bacterial infection has failed.
  • Routine referral if:

             o      the diagnosis is uncertain

             o      standard treatment has not controlled eczema

             o      you suspect contact dermatitis

             o      there is recurrent infection of the eczema

             o      the child’s eczema is causing significant social or psychological problems.

 

Practical tips for the busy GP >>

 

 

EGP 1. May 2008

If you encounter a problem with this page please email the web team
© Royal College of General Practitioners
Registered Charity Number - 223106